Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinda Pharmaceutical is a specialized pharmaceutical manufacturer based in Zibo, China, and operates as a key subsidiary of Shandong Xinhua Pharmaceutical. The company focuses on the development and large-scale production of finished dosage forms, particularly oral solids such as tablets, capsules, and granules. Its core therapeutic portfolio includes anti-infectives, cardiovascular medications, and gastrointestinal treatments. Shandong Xinda is recognized for its modern GMP-compliant production facilities and its significant role in the domestic Chinese healthcare market. By leveraging the extensive research and distribution network of the Xinhua Pharmaceutical Group, the company provides a wide range of essential generic and branded medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xinda Pharmaceutical.